RCUS
Arcus Biosciences Inc
24.90$
-0.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | -1,773.5% | -514.7% | -489.7% | 142.5% | -66.9% | 391.1% | -261.5% | -65.9% | -195.1% | |
| – | 184.9% | 43.9% | 23.9% | 5.4% | 1.0% | 5.4% | 6.8% | 3.9% | 4.0% | |
| – | 35.0% | 46.4% | 59.9% | 28.2% | 14.4% | 58.0% | 62.4% | 29.5% | 24.3% | |
| – | 57.5% | 40.2% | 67.9% | 28.0% | 14.2% | 67.9% | – | – | – | |
| – | 1,740.8% | 15.9% | 0.8% | 266.7% | -98.1% | 556.3% | -60.7% | 8.5% | -78.5% | |
| – | 390.2% | 44.8% | 12.8% | 3.9% | 6.8% | 5.4% | 20.5% | 2.3% | 0.8% | |
| – | -3,472.8% | -1,358.1% | 394.7% | -556.9% | -1.0% | -368.8% | 165.8% | -32.6% | 26.7% | |
| – | – | – | – | – | 1.3% | – | – | – | – | |
| – | 7,627.0% | 1,496.2% | -0.6% | -0.1% | 0.0% | 0.0% | – | – | – | |
| – | – | – | – | – | – | 0.0% | 0.0% | 18.2% | 19.8% | |
| – | 7,600.6% | 1,545.2% | 7.5% | 562.4% | 62.0% | 29.5% | 28.2% | 107.4% | 197.6% | |
| – | 2,354.3% | -327.6% | -87.5% | 148.0% | -6.7% | 51.8% | -67.5% | 8.9% | 29.1% | |
| – | -2,163.7% | -559.5% | -502.6% | 138.6% | -73.7% | 385.7% | -282.1% | -68.2% | -196.0% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.